Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Ascentage Pharma Received US$100 Million Option Payment from Takeda

Thursday, July 04, 2024

Ascentage Pharma a global biopharmaceutical company engaged in discovering developing and commercializing both firstinclass and bestinclass therapies for hematological malignancies announced today that on July in relation to the Exclusive Option A...

Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China

Thursday, July 04, 2024

Medigene AG an immunooncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors

Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Thursday, July 04, 2024

Scinai Immunotherapeutics Ltd a biotechnology company focused on developing inflammation and immunology biological products and on providing CDMO services

Ipsen Expands Collaboration and License Agreement for Development of Cabometyx® in Advanced Neuroendocrine Tumors Based on Positive Results from Phase III CABINET Trial

Wednesday, July 03, 2024

Ipsen today announced that it has expanded its collaboration and licensing agreement with Exelixis Inc for the development of Cabometyx cabozantinib in advanced pancreatic neuroendocrine tumors

Medsenic, Biosenic’s Subsidiary, Signed a New Set of Licensing and Commercialization Agreements With Phebra PTY Ltd.

Wednesday, July 03, 2024

BIOSENIC the clinicalstage company specializing in serious autoimmune and inflammatory diseases and cell therapy and its subsidiary Medsenic SAS today announce the signature of global licensing

Eppendorf Award for Young European Investigators 2024 goes to Clemens Plaschka, Austria

Wednesday, July 03, 2024

This year the Hamburg based life sicences company Eppendorf SE is awarding its prestigious research prize for the th time The independent jury chaired by Prof Laura Machesky Cambridge UK selected Dr Clemens Plaschka IMP Institute of Molecular Pathol...

From BIOTREE to ZETA Biosystem

Tuesday, July 02, 2024

BIOTREE a leading biopharmaceutical engineering and process equipment company in India has rebranded as ZETA Biosystem This change strengthens the companys integration

Altos Biologics Files for Approval of Aflibercept Biosimilar

Tuesday, July 02, 2024

Alteogen Inc announced on July st that its subsidiary Altos Biologics Inc has submitted Marketing Authorization Application to the European Medicines Agency for an aflibercept biosimilar ALTL developed by Alteogen The Phase clinical trial for ALTL c...

Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson

Tuesday, July 02, 2024

CanFite BioPharma Ltd a biotechnology company with a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases announced

Anbogen Therapeutics Announces Completion of A+ Round Financing to Advance ABT-301 Phase II Clinical Trial

Tuesday, July 02, 2024

Anbogen Therapeutics Inc a clinicalstage company dedicated to developing breakthrough cancer therapies has announced the successful closing of a USD M oversubscribed A round financing